Pretreatment with P2Y12 inhibitors in non-ST-segment-elevation acute coronary syndrome is clinically justified.
From the Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands. m.valgimigli@erasmusmc.nl.
Marco
M
Valgimigli
D054058:Acute Coronary Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D000077144:Clopidogrel; D006801:Humans; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D058921:Purinergic P2Y Receptor Antagonists; D000077144:Clopidogrel; D013988:Ticlopidine